Pharmaceutical
Biopharmaceutical
Biotechnology

AVEO Pharmaceuticals

$0.6626
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0101 (-1.47%) Today
-$0.0162 (-2.39%) As of 7:59 PM EDT after-hours

Why Robinhood?

You can buy or sell AVEO and other stocks, options, ETFs, and crypto commission-free!

About AVEO

AVEO Pharmaceuticals, Inc. Common Stock, also called AVEO Pharmaceuticals, is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Read More Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.

Employees
17
Headquarters
Cambridge, Massachusetts
Founded
2001
Market Cap
95.76M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.65M
High Today
$0.69
Low Today
$0.6601
Open Price
$0.69
Volume
2.84M
52 Week High
$3.59
52 Week Low
$0.4906

Collections

Pharmaceutical
Biopharmaceutical
Biotechnology
Health
Technology
Cancer Prevention
Medical
US

AVEO Earnings

-$0.18
-$0.13
-$0.08
-$0.03
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.